SK Bioscience Shares Knowledge on Infectious Disease Response at '2025 Sky Vision Symposium'

[Financial News] As concerns about the spread of infectious diseases grow, a gathering was organized for medical practitioners nationwide to share experiences from clinical settings and strategies for vaccination.
SK Bioscience announced on the 21st that it held the '2025 Sky Vision Symposium' at the Grand Walkerhill Hotel in Seoul over two days, from the 19th to the 20th. At this event, SK Bioscience shared the latest insights on infectious disease prevention and response strategies with over 100 internal medicine and pediatric practitioners nationwide.
This symposium, marking its 7th year, is an annual academic event that highlights practical vaccination strategies centered on voices from clinical settings.
Despite the ongoing heatwave, the venue was filled with high interest and participation. Practitioners on site reported that infectious respiratory diseases such as influenza, respiratory syncytial virus (RSV), mycoplasma, and pertussis have been on the rise since the first half of this year. They particularly agreed that such trends are likely to continue into the 2025-2026 season.
Nah Young-sook, director of Seohee Internal Medicine Clinic in Saha-gu, Busan, said, “Recently, with the decline in immunity due to the heat, even cases of shingles are increasing. Preventive vaccination is highly recommended as it is efficient in terms of both health management and cost compared to post-infection treatment.”
Jung Sun-hee, director of Samsung Kids Pediatrics and Adolescents Clinic in Eunpyeong-gu, Seoul, also emphasized, “Given that summer colds are rampant, there is a high possibility of simultaneous outbreaks of influenza and COVID-19 respiratory infections this fall and winter. Health authorities need to proactively prepare countermeasures in collaboration with frontline medical sites.”
The symposium focused on lectures by infectious disease and pediatric specialists, along with practical vaccination guidelines that can be directly applied to clinical settings.
Lee Jung-yong, president of the Korean Association of Internal Medicine, stated, “The Vision Symposium has established itself as a platform for exchanging information that provides practical help to clinical settings, beyond just an academic event. We hope to continue contributing to public health improvement through ongoing sharing of knowledge and experience.”
Yoo Soo-an, head of domestic marketing at SK Bioscience, emphasized, “The purpose of the Vision Symposium is to share disease information and vaccination strategies needed in the field. Advanced technology and products can only succeed with the trust of medical professionals. As a vaccine developer, we will continue to play a responsible role for medical sites.”


[email protected] Kang Joong-mo Reporter